"PAB still at very early stages and a long way from marketable product"
PaulEdward -
not so much very early stages now that authorities have labelled the orphan designation & this adds a hugely attractive proposition to any partners / suitors. From Phase II to market is often significantly shorter for orphan drugs with both shorter & smaller clinical trials required.
Completion of Phase I/IIa trial this year will give the best guidance but highly confident based on what has been seen to date through each cohort.
- Forums
- ASX - By Stock
- valuation time
"PAB still at very early stages and a long way from marketable...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 42344478 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9614841 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 42344478 | 0.003 |
20 | 31120001 | 0.002 |
14 | 51751998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9614841 | 11 |
0.005 | 2217679 | 5 |
0.006 | 9044918 | 10 |
0.007 | 399941 | 2 |
0.008 | 665910 | 2 |
Last trade - 07.11am 01/11/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable